Literature DB >> 29457362

A multinational observational investigation of illness perceptions and quality of life among patients with a Fontan circulation.

Christina E Holbein1, Nicholas D Fogleman1,2, Kevin Hommel1, Silke Apers3, Jessica Rassart3, Philip Moons3,4, Koen Luyckx3, Maayke A Sluman5, Junko Enomoto6, Bengt Johansson7, Hsiao-Ling Yang8, Mikael Dellborg4,9, Raghavan Subramanyan10, Jamie L Jackson11, Werner Budts3,12, Adrienne H Kovacs13, Stacey Morrison1, Martha Tomlin1, Kathy Gosney1, Alexandra Soufi14, Katrine Eriksen15, Corina Thomet3,16, Malin Berghammer4,17, Luis Alday18, Edward Callus19, Susan M Fernandes20, Maryanne Caruana21, Samuel Menahem22, Stephen C Cook23, Gwen R Rempel24, Kamila White25, Paul Khairy26, Shelby Kutty27, Gruschen Veldtman1.   

Abstract

OBJECTIVE: First, to compare QOL and illness perceptions between patients with a Fontan circulation and patients with anatomically simple defects (ie, atrial septal defects [ASD] or ventricular septal defects [VSD]). Second, to explore illness perceptions as a mediator of the association between congenital heart disease (CHD) diagnosis and QOL.
DESIGN: Cross-sectional observational study.
SETTING: Twenty-four cardiology centers from 15 countries across five continents. PATIENTS: Four hundred thirty-five adult patients with congenital heart disease (177 Fontan and 258 ASD/VSD) ages 18-83 years. OUTCOME MEASURES: QOL and illness perceptions were assessed by the Satisfaction With Life Scale and the Brief Illness Perceptions Questionnaire, respectively.
RESULTS: Patients with a Fontan circulation reported lower QOL (Wald Z = -3.59, p = <.001) and more negative perceptions of their CHD (Wald Z = -7.66, p < .001) compared with patients with ASD/VSD. After controlling for demographics, anxiety, depressive symptoms, and New York Heart Association functional class, path analyses revealed a significant mediation model, αβ = 0.15, p = .002, 95% CI = 0.06-0.25, such that CHD diagnosis was indirectly related to QOL through illness perceptions.
CONCLUSIONS: The Fontan sample's more negative perceptions of CHD were likely a reflection of life with a more complex defect. Illness perceptions appear to account for unique differences in QOL between groups of varying CHD complexity. Psychosocial screening and interventions may be important treatment components for patients with CHD, particularly those with Fontan circulations.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  Fontan circulation; congenital heart disease; illness perceptions; quality of life

Mesh:

Year:  2018        PMID: 29457362      PMCID: PMC5993574          DOI: 10.1111/chd.12583

Source DB:  PubMed          Journal:  Congenit Heart Dis        ISSN: 1747-079X            Impact factor:   2.007


  31 in total

1.  Medical factors that predict quality of life for young adults with congenital heart disease: What matters most?

Authors:  Jamie L Jackson; Lauren Hassen; Gina M Gerardo; Kathryn Vannatta; Curt J Daniels
Journal:  Int J Cardiol       Date:  2015-09-30       Impact factor: 4.164

Review 2.  The current state of cognitive therapy: a 40-year retrospective.

Authors:  Aaron T Beck
Journal:  Arch Gen Psychiatry       Date:  2005-09

3.  The Satisfaction With Life Scale.

Authors:  E Diener; R A Emmons; R J Larsen; S Griffin
Journal:  J Pers Assess       Date:  1985-02

4.  The brief illness perception questionnaire.

Authors:  Elizabeth Broadbent; Keith J Petrie; Jodie Main; John Weinman
Journal:  J Psychosom Res       Date:  2006-06       Impact factor: 3.006

Review 5.  A systematic review of resilience in the physically ill.

Authors:  Donna E Stewart; Tracy Yuen
Journal:  Psychosomatics       Date:  2011 May-Jun       Impact factor: 2.386

6.  Quality of Life of Adults With Congenital Heart Disease in 15 Countries: Evaluating Country-Specific Characteristics.

Authors:  Silke Apers; Adrienne H Kovacs; Koen Luyckx; Corina Thomet; Werner Budts; Junko Enomoto; Maayke A Sluman; Jou-Kou Wang; Jamie L Jackson; Paul Khairy; Stephen C Cook; Shanthi Chidambarathanu; Luis Alday; Katrine Eriksen; Mikael Dellborg; Malin Berghammer; Eva Mattsson; Andrew S Mackie; Samuel Menahem; Maryanne Caruana; Gruschen Veldtman; Alexandra Soufi; Anitra W Romfh; Kamila White; Edward Callus; Shelby Kutty; Steffen Fieuws; Philip Moons
Journal:  J Am Coll Cardiol       Date:  2016-05-17       Impact factor: 24.094

7.  Assessment of Quality of Life in Young Patients with Single Ventricle after the Fontan Operation.

Authors:  Karen Uzark; Victor Zak; Peter Shrader; Brian W McCrindle; Elizabeth Radojewski; James W Varni; Kaitlyn Daniels; Jill Handisides; Kevin D Hill; Linda M Lambert; Renee Margossian; Victoria L Pemberton; Wyman W Lai; Andrew M Atz
Journal:  J Pediatr       Date:  2015-12-10       Impact factor: 4.406

8.  The impact of illness perceptions and disease severity on quality of life in congenital heart disease.

Authors:  Claire E O'Donovan; Liz Painter; Boris Lowe; Hayley Robinson; Elizabeth Broadbent
Journal:  Cardiol Young       Date:  2015-01-20       Impact factor: 1.093

9.  The hospital anxiety and depression scale.

Authors:  A S Zigmond; R P Snaith
Journal:  Acta Psychiatr Scand       Date:  1983-06       Impact factor: 6.392

10.  Adults with congenital heart disease: psychological needs and treatment preferences.

Authors:  Adrienne H Kovacs; Katherine L Bendell; Jack Colman; Jeanine L Harrison; Erwin Oechslin; Candice Silversides
Journal:  Congenit Heart Dis       Date:  2009 May-Jun       Impact factor: 2.007

View more
  2 in total

Review 1.  Current research status on the psychological situation of adults with congenital heart disease.

Authors:  Caroline Andonian; Jürgen Beckmann; Sabina Biber; Peter Ewert; Sebastian Freilinger; Harald Kaemmerer; Renate Oberhoffer; Lars Pieper; Rhoia Clara Neidenbach
Journal:  Cardiovasc Diagn Ther       Date:  2018-12

2.  Impact of Family Socioeconomic Status on Health-Related Quality of Life in Children With Critical Congenital Heart Disease.

Authors:  Li Xiang; Zhanhao Su; Yiwei Liu; Yuan Huang; Xiaoling Zhang; Shoujun Li; Hao Zhang
Journal:  J Am Heart Assoc       Date:  2019-01-08       Impact factor: 5.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.